InvestorsHub Logo
Followers 16
Posts 1516
Boards Moderated 0
Alias Born 07/07/2015

Re: None

Thursday, 10/05/2017 12:58:19 PM

Thursday, October 05, 2017 12:58:19 PM

Post# of 423585
DES treatment. $1.4B revenue for Allergan last year.

http://www.marketwatch.com/story/this-billion-dollar-dry-eye-drug-is-behind-allergans-controversial-patent-deal-2017-10-05

Hopefully Amarin is planning a DES trial at some point.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News